Table 5 Basic characteristics of ADE reporting for metoprolol and bisoprolol
Characteristics | Number of reports, no. (%) | |
|---|---|---|
metoprolol | bisoprolol | |
Age | ||
0–17 | 877(1.3) | 295(0.7) |
18–44 | 4272(6.4) | 1404(3.2) |
45–59 | 7860(11.8) | 2804(6.3) |
>60 | 19,803(29.7) | 16,094(36.4) |
Unknown or missing | 33,846(50.8) | 23,627(53.4) |
Sex | ||
Female | 24,271(36.4) | 11,953(27.0) |
Male | 18,998(28.5) | 10,136(22.9) |
Unknown or missing | 23,389(35.1) | 22,135(50.1) |
Reporting time | ||
2004.1-2014.12 | 18,215(27.3) | 3086(7.0) |
2015.1-2018.12 | 20,169(30.3) | 11,130(25.2) |
2019.1-2024.3 | 28,274(42.4) | 30,008(67.9) |
Country The United States | 31,259(55.7) | 629(2.6) |
Canada | 2177(3.9) | 2135(8.9) |
Germany | 3415(6.1) | 2187(9.1) |
The United Kingdom | 173(0.3) | 317(1.3) |
Sweden | 980(1.7) | 141(0.6) |
Unknown or missing | 18,129(32.3) | 18,715(77.6) |